PC3 - Accelerating a medicine's path to patients - Beyond Registration

Moderator(s)

• 

  Matthew Zierhut, PhD, MBA (he/him/his)

  Vice President, Certara Drug Development Solutions
  Certara
  San Diego, California, United States

Presentations:

• 10:30 AM - 10:45 AM MDT

  Dose selection and go/no-go decisions in a second indication by leveraging published clinical trial data for drugs/classes approved in multiple indications
  

  Speaker: Paul M. Diderichsen, PhD (he/him/his) – Certara USA, Inc.
• 10:45 AM - 11:00 AM MDT

  Early Health Economic Modeling: Preparing for Market Access Challenges
  

  Speaker: Peter L. Quon, MPH (he/him/his) – Regeneron
• 11:00 AM - 11:15 AM MDT

  Improving future decisions by evaluating accuracy of past decisions based on pharmacometrics and statistical modeling
  

  Speaker: Fei Chen, PhD – Johnson & Johnson Innovative Medicine